Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis.
BACKGROUND
Thrombosis of a portal vein conduit after liver transplant is an uncommon clinical situation. Percutaneous thrombolytic therapy for this condition has not been widely described.


METHODS
We describe a case of thrombosis of a portal vein (PV) conduit subsequent to orthotopic liver transplantation that was successfully treated by percutaneous portal vein thrombolysis by using tissue plasminogen activator, angioplasty, and endovascular stent placement.


RESULTS
A satisfactory outcome was achieved with a patent portal vein, on ultrasound, at 8-month follow-up.


CONCLUSIONS
A percutaneous transhepatic approach to treatment of thrombosis of a portal vein conduit appears to be a promising technique to use to avoid surgery, with good medium-term results.
Bhattacharjya
T
T
Department of Radiodiagnosis, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
Olliff
S P
SP
Bhattacharjya
S
S
Mirza
D F
DF
McMaster
P
P
D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology; D008875:Middle Aged; D011169:Portal Vein; D011183:Postoperative Complications / Q000628:therapy*; D015607:Stents; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000209:etiology / Q000628:therapy*
D005343:Fibrinolytic Agents; D006493:Heparin